An Internet-based Self-management Program for Adolescents With Arthritis
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01572896 |
Recruitment Status :
Completed
First Posted : April 6, 2012
Last Update Posted : April 4, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Arthritis, Juvenile Idiopathic | Behavioral: Taking Charge: Managing JIA Online Behavioral: Standard Medical Care and JIA Resource Center | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 333 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Participant) |
Primary Purpose: | Treatment |
Official Title: | An Internet-based Self-management Program for Adolescents With Arthritis: A Randomized Controlled Trial |
Study Start Date : | April 2012 |
Actual Primary Completion Date : | March 2016 |
Actual Study Completion Date : | March 2017 |

Arm | Intervention/treatment |
---|---|
Experimental: Taking Charge Experimental Group |
Behavioral: Taking Charge: Managing JIA Online
In addition to standard medical care, adolescents in the experimental group will receive the "Taking Charge: Managing JIA Online" Internet self-management program. The intervention is a 12-module interactive multi-component treatment protocol - that consists of JIA-specific education, self-management strategies, and social support - that is available in English and French. |
Active Comparator: Control Group |
Behavioral: Standard Medical Care and JIA Resource Center
The control group is designed to control for the potential effects on outcomes of time, attention and computer use during the intervention and through the 9-month follow-up period. In addition to standard medical care, adolescents in the attention control group will be provided with access to a self-guided patient education study website, which will have two components: basic patient educational materials about JIA ("JIA Resource Centre") and online assessments. |
- Pain [ Time Frame: 12 months ]Pain will be measured using the Recalled Pain Inventory - Short Form.91 The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations. This 11-item measure has evidence of construct validity
- Health-related Quality of Life (HRQL) [ Time Frame: Baseline ]HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13 Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
- Pain [ Time Frame: Baseline ]Pain will be measured using the Recalled Pain Inventory - Short Form.91 The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations. This 11-item measure has evidence of construct validity
- Pain [ Time Frame: 3months ]Pain will be measured using the Recalled Pain Inventory - Short Form.91 The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations. This 11-item measure has evidence of construct validity
- Health-related Quality of Life (HRQL) [ Time Frame: 6 months ]HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13 Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
- Pain [ Time Frame: 6 months ]Pain will be measured using the Recalled Pain Inventory - Short Form.91 The RPI measures current as well as least, average and worst pain intensity, pain unpleasantness, and pain interference ratings over the past week with items rated on a 11-point numerical rating scale (NRS) (e.g., 0 = 'no pain' to 10 = 'severe pain') and painful body locations. This 11-item measure has evidence of construct validity
- Health-related Quality of Life (HRQL) [ Time Frame: 3 months ]HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13 Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
- Health-related Quality of Life (HRQL) [ Time Frame: 12 months ]HRQL will be measured using the teen and parent PedsQL Rheumatology Modules.13 Both of the PedsQL rheumatology modules contain a 22-item self-report and parent scale with five subscales: pain and hurt, daily activities, treatment, worry, and communication.
- Emotional Symptoms [ Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention ]Anxiety and depression will each be assessed using two, separate 8-item PROMIS (Patient Reported Outcomes Measurement Information System) scales.
- Adherence [ Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention ]Adherence to medical treatment will be assessed using the 34-item Child Adherence Report Questionnaire (CARQ)
- Pain Coping [ Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention ]Pain coping will be measured using the 18-item Pain Coping Questionnaire106, which is an internationally used measure of pain coping strategies in the pediatric population and has been validated in youth with arthritis.
- Juvenile Idiopathic Arthritis (JIA) [ Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention ]JIA-specific knowledge will be measured using 9-items from the Medical Issues, Exercise, Pain and Social Support Questionnaire (MEPS).
- Self-Efficacy [ Time Frame: Baseline, 3 months, 6 months and 12 months post-intervention ]Self-efficacy will be measured using the Children's Arthritis Self-Efficacy (CASE) scale which is an 11-item measure.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 18 Years (Child, Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age ≥12 and ≤ 18 years.
- Diagnosed with JIA (using International League of Associations for Rheumatology classification criteria)83 by their rheumatologist.
- Adolescents and parent/ primary caregiver are able to speak and read either English or French.
- Participants are willing and able to complete online measures. There will be no restrictions on medication use for this study.
Exclusion Criteria:
- Cognitive impairments (as assessed by reviewing medical chart and consultation with the patient's rheumatologist)
-
Major co-morbid illnesses which may mitigate HRQL assessment
- Excluded medical illnesses: inflammatory bowel disease, fibromyalgia, cancer, genetic disorders, diabetes
- Excluded psychiatric conditions: post-traumatic stress disorder, panic disorder, bipolar disorder, psychosis, depression and major mood disorders. Adolescents currently on medications for major depression, bipolar disorder or psychosis would also be excluded.
- Adolescents that are currently participating in other CBT interventions.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01572896
Canada, Ontario | |
Hamilton Health Sciences | |
Hamilton, Ontario, Canada, L8S 4K1 | |
The Hospital for Sick Children | |
Toronto, Ontario, Canada, M5V1X8 | |
Canada | |
Alberta Children's Hospital | |
Calgary, Canada | |
Stollery Children's Hospital | |
Edmonton, Canada | |
IWK Health Centre | |
Halifax, Canada | |
Montreal Children's Hospital | |
Montreal, Canada | |
Children's Hospital of Eastern Ontario | |
Ottawa, Canada | |
Royal University | |
Saskatoon, Canada | |
Janeway Children's Health and Rehabilitation Centre | |
St. Johns, Canada | |
BC Children's Hospital | |
Vancouver, Canada | |
Winnepeg Children's Hospital | |
Winnepeg, Canada |
Principal Investigator: | Jennifer N Stinson, RN, PhD, CPNP | The Hospital for Sick Children |
Responsible Party: | Jennifer Stinson, Clinician Scientist, Clinical Nurse Specialist/NP, The Hospital for Sick Children |
ClinicalTrials.gov Identifier: | NCT01572896 |
Other Study ID Numbers: |
1000028028 |
First Posted: | April 6, 2012 Key Record Dates |
Last Update Posted: | April 4, 2017 |
Last Verified: | March 2017 |
adoloescent internet self-management managing JIA |
Arthritis Arthritis, Juvenile Joint Diseases Musculoskeletal Diseases |
Rheumatic Diseases Connective Tissue Diseases Autoimmune Diseases Immune System Diseases |